5. 進行性核上性麻痺 Progressive supranuclear palsy Clinical trials / Disease details

臨床試験数 : 89 / 薬物数 : 107 - (DrugBank : 40) / 標的遺伝子数 : 65 - 標的パスウェイ数 : 108

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04734379 (ClinicalTrials.gov)	January 22, 2021	18/1/2021	Rho Kinase (ROCK) Inhibitor in Tauopathies - 1	A Phase 2a Open-Label Preliminary Safety, Tolerability, and Biomarker Study of Oral Fasudilin Patien ...	Progressive Supranuclear Palsy;Corticobasal Syndrome	Drug: Fasudil	Woolsey Pharmaceuticals	NULL	Active, not recruiting	35 Years	80 Years	All	15	Phase 2	United States